Tygacil Drug Use Investigation (TIGER)

Pfizer

Status: Completed

Conditions: Skin Disease, Infectious; Intra-Abdominal Infections

Treatments: Drug: Tigecycline (Tygacil)

Study type: Observational

Funder types: Industry

Identifiers

NCT01789905

B1811187

Details and patient eligibility

About

Secondary Data Collection Study; safety and effectiveness of Tigecycline .under Japanese medical practice

Enrollment: 116 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• All patients who are prescribed tigecycline (Tygacil).

Exclusion criteria

• Subject who have not been prescribed tigecycline (Tygacil).

Trial design

116 participants in 1 patient group

Tigecycline (Tygacil)

Description:

Subjects who are treated with tigecycline

Treatment:

Drug: Tigecycline (Tygacil)